drugset / Trial / NCT00441415

Efficacy and Safety of Fixed Combination Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris

NCT00441415

Phase 3 Completed 272 enrolled Galderma R&D
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to demonstrate the non-inferior efficacy of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel when compared to Clindamycin 1% / Benzoyl Peroxide 5% Gel in Subjects with acne vulgaris after a 12-week treatment period.

Timeline

Start
2007-02
Primary completion
2007-10
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Adapalene Other / unclassified 0.1 %
Subject Benzoyl Peroxide Other / unclassified 2.5 %

Indications